一品红：全资子公司获得注射用硫酸艾沙康唑注册证书

Group 1 - The company, Yipinhong, announced that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has received the drug registration certificate for injectable isavuconazole from the National Medical Products Administration [1] - Injectable isavuconazole is indicated for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis [1]